Pfizer and GSK had two different performances last year

The two companies once competing for the first and second in sales in the pharmaceutical industry, Pfizer Korea and GSK Korea, have received contrary management performance in 2014. Pfizer Korea achieved the most sales, KRW 628 billion, among multinational pharmaceutical companies and the 190% increased sales compared to the year before.

GSK Korea was not able to reverse poor performance in 20...